Summary

Persistence Market Research has recently published an extensive report on the global drug delivery devices market. This report provides a detailed assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, offering in-depth insights into the market structure.

Key Insights:

• Drug Delivery Devices Market Size (2024E): USD 44.2 Bn
• Projected Market Value (2033F): USD 90.2 Bn
• Global Market Growth Rate (CAGR 2024 to 2033): 8.2%

Scope of the Report: Drug Delivery Devices Market

Drug delivery devices are critical for the efficient and controlled administration of medications to patients. These devices encompass a range of products including insulin pens, inhalers, transdermal patches, and implantable drug delivery systems, all designed to improve therapeutic outcomes and enhance patient compliance. The market serves various therapeutic areas, including diabetes management, respiratory diseases, and cancer treatment. Growth in the drug delivery devices market is driven by the increasing prevalence of chronic diseases, advancements in drug delivery technologies, and the rising demand for self-administered drug delivery solutions.

Market Growth Drivers:

Several factors are driving the growth of the global drug delivery devices market. The rising prevalence of chronic conditions such as diabetes and asthma necessitates continuous and efficient drug delivery solutions. An aging population and the associated increase in age-related health conditions further fuel the demand for advanced drug delivery systems. Technological innovations, including smart drug delivery devices and advancements in micro-needle technologies, contribute to improved patient adherence and precise drug dosing. Additionally, the focus on personalized medicine and home-based care solutions expands the application of drug delivery devices across various healthcare settings.

Market Restraints:

Despite the promising growth outlook, the drug delivery devices market faces challenges including high costs, regulatory hurdles, and complex manufacturing processes. Developing and producing advanced drug delivery systems requires significant investment in R&D and adherence to stringent regulatory standards, which can limit market entry for smaller players. The high cost of sophisticated devices may restrict accessibility, especially in emerging economies with limited healthcare budgets. Overcoming these economic and regulatory barriers necessitates collaborative efforts from industry stakeholders and policymakers to enhance market accessibility and affordability.

Market Opportunities:

The drug delivery devices market offers significant growth opportunities driven by technological advancements, demographic trends, and evolving healthcare delivery models. The integration of digital technologies, such as connected inhalers and smart insulin pens, enhances patient engagement and treatment outcomes. The expansion of telehealth services and the growing trend towards home-based healthcare create new opportunities for deploying drug delivery devices. Additionally, innovations in drug delivery systems, such as biodegradable implants and sustained-release formulations, hold promise for addressing unmet medical needs and driving market expansion.

Key Questions Answered in the Report:

• What are the primary drivers of growth in the global drug delivery devices market?
• Which types of drug delivery devices are experiencing the highest adoption across different therapeutic areas?
• How are technological advancements reshaping the competitive landscape of the drug delivery devices market?
• Who are the key players in the drug delivery devices market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global drug delivery devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global drug delivery devices market, including Medtronic plc, Johnson & Johnson, and Abbott Laboratories, focus on innovation, product differentiation, and strategic partnerships to secure a competitive advantage. These companies invest in R&D to develop advanced drug delivery solutions, including smart devices, wearable technologies, and implantable systems, catering to diverse therapeutic needs. Collaborations with healthcare providers, pharmaceutical companies, and regulatory bodies support market access and promote the adoption of new technologies. Emphasizing clinical research, user experience, and patient-centered design fosters market growth and enhances treatment outcomes in the evolving drug delivery devices landscape.

Key Companies Profiled:

• Eli Lilly and Company
• Becton Dickinson & Co.
• Novo Nordisk
• Sanofi
• Johnson & Johnson
• Roche
• Pfizer
• AbbVie
• Mylan N.V. (Viatris)
• Insulet corporation
• Medtronic Plc

Drug Delivery Devices Market Segmentation

By Product
• Self-Injectors
• Auto Injectors
• Wearable Injectors

By Usage
• Reusable Devices
• Disposable Devices

By Route of Administration
• Transdermal
• Subcutaneous
• Intramuscular

By Sales Channel:
• Hospitals
• Specialty Clinics
• Retail Pharmacy Chains

By Applications
• Diabetes
• Cancer
• Hormonal Therapy

By Region
• North America
• Latin America
• Europe
• South Asia & Oceania
• East Asia
• The Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Drug Delivery System Market Snapshot, 2024-2033
1.2. Market Opportunity Assessment, 2024-2033 , US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Adoption / Usage Analysis, By Region
2.4. PESTLE Analysis
2.5. Drug Delivery System Market: Value Chain Analysis
2.6. Porter Five Force’s Analysis
2.7. Macro-Economic Factors
2.7.1. Global Healthcare Outlook
2.7.2. Global Medical Devices Industry Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory Scenario, by Country
2.9.1. Regulatory Frameworks in U.S.
2.9.2. Regulatory Frameworks in Canada
2.9.3. Regulatory Frameworks in Europe
2.9.4. Regulatory Frameworks in Brazil
2.9.5. Regulatory Frameworks in China
2.9.6. Regulatory Frameworks in Japan
2.9.7. Regulatory Frameworks in India
2.9.8. Regulatory Frameworks in Australia
3. Global Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )
3.1. Key Highlights
3.1.1. Market Value (US$ in Bn ) and Volume (in Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Bn ) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2019-2023
3.2.2. Current Market Size Forecast, 2024-2033
3.3. Global Drug Delivery System Market Outlook: Product
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Bn ) & Volume (in Units) Analysis by Product, 2019-2023
3.3.3. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
3.3.3.1. Self-Injector
3.3.3.2. Pre-Filled Needle Free Injectors
3.3.3.3. Auto Injectors
3.3.3.4. Wearable Injectors
3.3.3.5. Insulin Pens
3.3.3.6. Implantable Drug Delivery
3.3.3.7. Transdermal Patches
3.4. Market Attractiveness Analysis: Product
3.5. Global Drug Delivery System Market Outlook: Usage
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Bn ) Analysis by Usage, 2019-2023
3.5.3. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
3.5.3.1. Reusable Devices
3.5.3.2. Disposable Devices
3.6. Market Attractiveness Analysis: Usage
3.7. Global Drug Delivery System Market Outlook: Application
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Bn ) Analysis by Application, 2019-2023
3.7.3. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
3.7.3.1. Diabetes
3.7.3.2. Anaphylaxis
3.7.3.3. Rheumatoid Arthritis
3.7.3.4. Cancer
3.7.3.5. Hormonal Therapy
3.7.3.6. Ophthalmology
3.7.3.7. Others
3.8. Market Attractiveness Analysis: Application
3.9. Global Drug Delivery System Market Outlook: Route of Administration
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Bn ) Analysis by Route of Administration, 2019-2023
3.9.3. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
3.9.3.1. Transdermal
3.9.3.2. Subcutaneous
3.9.3.3. Intramuscular
3.9.3.4. Implantable
3.10. Market Attractiveness Analysis: Route of Administration
3.11. Global Drug Delivery System Market Outlook: Sales Channel
3.11.1. Introduction / Key Findings
3.11.2. Historical Market Size (US$ Bn ) Analysis by Sales Channel, 2019-2023
3.11.3. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
3.11.3.1. Hospitals
3.11.3.2. Specialty Clinics
3.11.3.3. Retail Pharmacy Chains
3.11.3.4. Drug Stores
3.11.3.5. Online Sales Channel
3.12. Market Attractiveness Analysis: Sales Channel
4. Global Drug Delivery System Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Bn ) Analysis by Region, 2019-2023
4.3. Current Market Size (US$ Bn ) Forecast by Region, 2024-2033
4.3.1. North America
4.3.2. Latin America
4.3.3. Western Europe
4.3.4. Eastern Europe
4.3.5. East Asia
4.3.6. South Asia & Pacific
4.3.7. Middle East & Africa
4.4. Market Attractiveness Analysis: Region
5. North America Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
5.2.1. By Country
5.2.2. By Product
5.2.3. By Usage
5.2.4. By Application
5.2.5. By Route of Administration
5.2.6. By Sales Channel
5.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
5.3.1. U.S.
5.3.2. Canada
5.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
5.4.1. Self-Injector
5.4.2. Pre-Filled Needle Free Injectors
5.4.3. Auto Injectors
5.4.4. Wearable Injectors
5.4.5. Insulin Pens
5.4.6. Implantable Drug Delivery
5.4.7. Transdermal Patches
5.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
5.5.1. Reusable Devices
5.5.2. Disposable Devices
5.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
5.6.1. Diabetes
5.6.2. Anaphylaxis
5.6.3. Rheumatoid Arthritis
5.6.4. Cancer
5.6.5. Hormonal Therapy
5.6.6. Ophthalmology
5.6.7. Others
5.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
5.7.1. Transdermal
5.7.2. Subcutaneous
5.7.3. Intramuscular
5.7.4. Implantable
5.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
5.8.1. Hospitals
5.8.2. Specialty Clinics
5.8.3. Retail Pharmacy Chains
5.8.4. Drug Stores
5.8.5. Online Sales Channel
5.9. Market Attractiveness Analysis
6. Western Europe Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
6.2.1. By Country
6.2.2. By Product
6.2.3. By Usage
6.2.4. By Application
6.2.5. By Route of Administration
6.2.6. By Sales Channel
6.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
6.3.1. Germany
6.3.2. Italy
6.3.3. France
6.3.4. U.K.
6.3.5. Spain
6.3.6. BENELUX
6.3.7. Nordic Countries
6.3.8. Rest of Western Europe
6.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
6.4.1. Self-Injector
6.4.2. Pre-Filled Needle Free Injectors
6.4.3. Auto Injectors
6.4.4. Wearable Injectors
6.4.5. Insulin Pens
6.4.6. Implantable Drug Delivery
6.4.7. Transdermal Patches
6.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
6.5.1. Reusable Devices
6.5.2. Disposable Devices
6.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
6.6.1. Diabetes
6.6.2. Anaphylaxis
6.6.3. Rheumatoid Arthritis
6.6.4. Cancer
6.6.5. Hormonal Therapy
6.6.6. Ophthalmology
6.6.7. Others
6.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
6.7.1. Transdermal
6.7.2. Subcutaneous
6.7.3. Intramuscular
6.7.4. Implantable
6.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
6.8.1. Hospitals
6.8.2. Specialty Clinics
6.8.3. Retail Pharmacy Chains
6.8.4. Drug Stores
6.8.5. Online Sales Channel
6.9. Market Attractiveness Analysis
7. Eastern Europe Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
7.2.1. By Country
7.2.2. By Product
7.2.3. By Usage
7.2.4. By Application
7.2.5. By Route of Administration
7.2.6. By Sales Channel
7.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
7.3.1. Poland
7.3.2. Hungary
7.3.3. Russia
7.3.4. Balkan & Baltic
7.3.5. Rest of Eastern Europe
7.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
7.4.1. Self-Injector
7.4.2. Pre-Filled Needle Free Injectors
7.4.3. Auto Injectors
7.4.4. Wearable Injectors
7.4.5. Insulin Pens
7.4.6. Implantable Drug Delivery
7.4.7. Transdermal Patches
7.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
7.5.1. Reusable Devices
7.5.2. Disposable Devices
7.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
7.6.1. Diabetes
7.6.2. Anaphylaxis
7.6.3. Rheumatoid Arthritis
7.6.4. Cancer
7.6.5. Hormonal Therapy
7.6.6. Ophthalmology
7.6.7. Others
7.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
7.7.1. Transdermal
7.7.2. Subcutaneous
7.7.3. Intramuscular
7.7.4. Implantable
7.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
7.8.1. Hospitals
7.8.2. Specialty Clinics
7.8.3. Retail Pharmacy Chains
7.8.4. Drug Stores
7.8.5. Online Sales Channel
7.9. Market Attractiveness Analysis
8. East Asia Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
8.2.1. By Country
8.2.2. By Product
8.2.3. By Usage
8.2.4. By Application
8.2.5. By Route of Administration
8.2.6. By Sales Channel
8.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
8.4.1. Self-Injector
8.4.2. Pre-Filled Needle Free Injectors
8.4.3. Auto Injectors
8.4.4. Wearable Injectors
8.4.5. Insulin Pens
8.4.6. Implantable Drug Delivery
8.4.7. Transdermal Patches
8.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
8.5.1. Reusable Devices
8.5.2. Disposable Devices
8.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
8.6.1. Diabetes
8.6.2. Anaphylaxis
8.6.3. Rheumatoid Arthritis
8.6.4. Cancer
8.6.5. Hormonal Therapy
8.6.6. Ophthalmology
8.6.7. Others
8.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
8.7.1. Transdermal
8.7.2. Subcutaneous
8.7.3. Intramuscular
8.7.4. Implantable
8.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
8.8.1. Hospitals
8.8.2. Specialty Clinics
8.8.3. Retail Pharmacy Chains
8.8.4. Drug Stores
8.8.5. Online Sales Channel
8.9. Market Attractiveness Analysis
9. South Asia & Pacific Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
9.2.1. By Country
9.2.2. By Product
9.2.3. By Usage
9.2.4. By Application
9.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
9.3.1. India
9.3.2. Thailand
9.3.3. Indonesia
9.3.4. Malaysia
9.3.5. Philippines
9.3.6. Vietnam
9.3.7. Australia & New Zealand
9.3.8. Rest of South Asia & Pacific
9.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
9.4.1. Self-Injector
9.4.2. Pre-Filled Needle Free Injectors
9.4.3. Auto Injectors
9.4.4. Wearable Injectors
9.4.5. Insulin Pens
9.4.6. Implantable Drug Delivery
9.4.7. Transdermal Patches
9.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
9.5.1. Reusable Devices
9.5.2. Disposable Devices
9.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
9.6.1. Diabetes
9.6.2. Anaphylaxis
9.6.3. Rheumatoid Arthritis
9.6.4. Cancer
9.6.5. Hormonal Therapy
9.6.6. Ophthalmology
9.6.7. Others
9.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
9.7.1. Transdermal
9.7.2. Subcutaneous
9.7.3. Intramuscular
9.7.4. Implantable
9.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
9.8.1. Hospitals
9.8.2. Specialty Clinics
9.8.3. Retail Pharmacy Chains
9.8.4. Drug Stores
9.8.5. Online Sales Channel
9.9. Market Attractiveness Analysis
10. Latin America Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
10.2.1. By Country
10.2.2. By Product
10.2.3. By Usage
10.2.4. By Application
10.2.5. By Route of Administration
10.2.6. By Sales Channel
10.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Chile
10.3.4. Rest of Latin America
10.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
10.4.1. Self-Injector
10.4.2. Pre-Filled Needle Free Injectors
10.4.3. Auto Injectors
10.4.4. Wearable Injectors
10.4.5. Insulin Pens
10.4.6. Implantable Drug Delivery
10.4.7. Transdermal Patches
10.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
10.5.1. Reusable Devices
10.5.2. Disposable Devices
10.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
10.6.1. Diabetes
10.6.2. Anaphylaxis
10.6.3. Rheumatoid Arthritis
10.6.4. Cancer
10.6.5. Hormonal Therapy
10.6.6. Ophthalmology
10.6.7. Others
10.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
10.7.1. Transdermal
10.7.2. Subcutaneous
10.7.3. Intramuscular
10.7.4. Implantable
10.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
10.8.1. Hospitals
10.8.2. Specialty Clinics
10.8.3. Retail Pharmacy Chains
10.8.4. Drug Stores
10.8.5. Online Sales Channel
10.9. Market Attractiveness Analysis
11. Middle East & Africa Drug Delivery System Market Outlook: Historical (2019-2023) and Forecast ( 2024-2033 )
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn ) Analysis by Market, 2019-2023
11.2.1. By Country
11.2.2. By Product
11.2.3. By Usage
11.2.4. By Application
11.2.5. By Route of Administration
11.2.6. By Sales Channel
11.3. Current Market Size (US$ Bn ) Forecast by Country, 2024-2033
11.3.1. Kingdom of Saudi Arabia
11.3.2. GCC Countries
11.3.3. Turkey
11.3.4. Israel
11.3.5. Other African Union
11.3.6. South Africa
11.3.7. Rest of Middle East and Africa
11.4. Current Market Size (US$ Bn ) & Volume (in Units) Forecast by Product, 2024-2033
11.4.1. Self-Injector
11.4.2. Pre-Filled Needle Free Injectors
11.4.3. Auto Injectors
11.4.4. Wearable Injectors
11.4.5. Insulin Pens
11.4.6. Implantable Drug Delivery
11.4.7. Transdermal Patches
11.5. Current Market Size (US$ Bn ) Forecast by Usage, 2024-2033
11.5.1. Reusable Devices
11.5.2. Disposable Devices
11.6. Current Market Size (US$ Bn ) Forecast by Application, 2024-2033
11.6.1. Diabetes
11.6.2. Anaphylaxis
11.6.3. Rheumatoid Arthritis
11.6.4. Cancer
11.6.5. Hormonal Therapy
11.6.6. Ophthalmology
11.6.7. Others
11.7. Current Market Size (US$ Bn ) Forecast by Route of Administration, 2024-2033
11.7.1. Transdermal
11.7.2. Subcutaneous
11.7.3. Intramuscular
11.7.4. Implantable
11.8. Current Market Size (US$ Bn ) Forecast by Sales Channel, 2024-2033
11.8.1. Hospitals
11.8.2. Specialty Clinics
11.8.3. Retail Pharmacy Chains
11.8.4. Drug Stores
11.8.5. Online Sales Channel
11.9. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2024
12.2. Market Structure
12.2.1. Competition Intensity Mapping by Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Eli Lilly and Company
12.3.1.1. Overview
12.3.1.2. Segments and Product
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Becton Dickinson And Co.
12.3.2.1. Overview
12.3.2.2. Segments and Product
12.3.2.3. Key Financials
12.3.2.4. Market Developments
12.3.2.5. Market Strategy
12.3.3. Novo Nordisk
12.3.3.1. Overview
12.3.3.2. Segments and Product
12.3.3.3. Key Financials
12.3.3.4. Market Developments
12.3.3.5. Market Strategy
12.3.4. Sanofi
12.3.4.1. Overview
12.3.4.2. Segments and Product
12.3.4.3. Key Financials
12.3.4.4. Market Developments
12.3.4.5. Market Strategy
12.3.5. Johnson & Johnson
12.3.5.1. Overview
12.3.5.2. Segments and Product
12.3.5.3. Key Financials
12.3.5.4. Market Developments
12.3.5.5. Market Strategy
12.3.6. Roche
12.3.6.1. Overview
12.3.6.2. Segments and Product
12.3.6.3. Key Financials
12.3.6.4. Market Developments
12.3.6.5. Market Strategy
12.3.7. Pfizer
12.3.7.1. Overview
12.3.7.2. Segments and Product
12.3.7.3. Key Financials
12.3.7.4. Market Developments
12.3.7.5. Market Strategy
12.3.8. AbbVie
12.3.8.1. Overview
12.3.8.2. Segments and Product
12.3.8.3. Key Financials
12.3.8.4. Market Developments
12.3.8.5. Market Strategy
12.3.9. Mylan N.V. (Viatris)
12.3.9.1. Overview
12.3.9.2. Segments and Product
12.3.9.3. Key Financials
12.3.9.4. Market Developments
12.3.9.5. Market Strategy
12.3.10. Insulet corporation
12.3.10.1. Overview
12.3.10.2. Segments and Product
12.3.10.3. Key Financials
12.3.10.4. Market Developments
12.3.10.5. Market Strategy
12.3.11. Medtronic Plc
12.3.11.1. Overview
12.3.11.2. Segments and Product
12.3.11.3. Key Financials
12.3.11.4. Market Developments
12.3.11.5. Market Strategy
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations